12 May 2014
www.regonline.co.uk/cancerscreen2014
This will be held at Cineworld: The O2, Peninsula Square, London, SE10 0DX, United Kingdom
This event will discuss current research and clinical trials for the prevention of cancer, focussing on screening, early detection and chemoprevention. The meetings will be run in an informal setting with plenty of opportunity for networking and debate.
The Deadline for abstract submissions for oral presentation is Feb 10th 2014
Abstracts for poster presentation only can be submitted up to two weeks before the event
.
You can download the instructions for authors at
www.euroscicon.com/AbstractsForOralAndPosterPresentation.pdf
This event has CPD accreditation and is part of the
Controlling Cancer Summit 2014 –www.controllingcancersummit2014.com
This summit comprises of three separate events
1. Advances in Cancer Screening and Prevention Research Monday, 12 May 2014, www.regonline.co.uk/cancerscreen2014
2. Cancer Biomarker Discovery and Assay Development Tuesday, 13 May 2014 www.regonline.co.uk/cancerbiomark2014
3. Anti-Cancer Therapeutics: From research to trials to treatment Wednesday, 14 May 2014
www.regonline.co.uk/anticancer2014
Talks include
- Mammography Screening for Breast Cancer. Is it living up to its promise
Dr Anthony Miller, Professor Emeritus, Dalla Lana School of Public Health, University of Toronto, Canada
- Epigenetic assays and clinical diagnostic development
Dr Mark Eccleston, Managing Director,OncoLytika, UK
- Quality Control in Cervical Cancer Screening
Dr Alenka Repše Fokter, MD, Ph.D, MIAC, cytopathologist, Dept. of Pathology and Cytology, Celje general Hospital, Slovenia
- The European Prostate cancer screening trial ERSPC: outcomes and methods for risk stratification.
Dr Monique Roobol, Associate professor, epidemiologist, Erasmus University Medical center, Rotterdam, The Netherlands
- Paediatric lymphoma: diagnosis, biomonitoring and therapy
Dr Suzanne Turner, Leukaemia and Lymphoma Research Lecturer, Department of Pathology, University of Cambridge, UK
- Translating antibodies engineered with IgE Fc regions to elicit enhanced effector functions for cancer therapy
Dr. Sophia N. Karagiannis, Senior Research Fellow in Translational Cancer Immunology, Head of Cancer Antibody Discovery and Immunotherapy, St. John’s Institute of Dermatology, Division of Genetics and Molecular Medicine, King’s College London School of Medicine, UK
- Estonian experience in establishing a cancer screening registry: opportunities and challenges of the e-health era
Dr Piret Veerus, Senior researcher, National Institute for Health Development, Estonia
- Targeting leukemic stem cells to improve treatment of chronic myeloid leukemia.
Dr. Xiaoyan Jiang, Senior Scientist and Associate Professor, Terry Fox Laboratory, BC Cancer Agency Medical Genetics, University of British Columbia, Canada
A late registration fee applies after Feb 20th 2014
After this time the fees double, so make sure you register early!
